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Introduction. A critical review to the use of tricyclic “old” an-
tidepressants.
Methods. Present guidelines for treatment of depression and
recommendations from textbooks as reports on special indica-
tions were reviewed and considered for this opinion statement.
Results. “Old” tricyclic antidepressants (TCAs) have consider-
able side effects more than modern antidepressant (ADs) like
SSRIs and others. Especially the use of TCAs in people over 65
years is associated with increased risks, mainly cardiovascular
risks and anticholinergic side effects. TCAs have advantages in
pain treatment, in severe depression and in therapy-resistant
depression, at least in certain individuals. The mechanisms re-
sponsible for advantages are poorly understood and may in-
clude anti-inflammatory effects. A newly described
intercalation mechanism, at the end eliciting an anti-inflam-
matory effect, may represent such previously unrecognized type
of action which is common for neuroleptics and several TCAs
but also few modern ADs.
Conclusion. TCAs remain to represent a valuable part of psy-
chopharmacological equipment with several relevant advan-
tages, though with an increased risk for side effects.
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